Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Toxic or drug-related embryofetopathy
Acitretin/etretinate embryopathy
Acitretin/Etretinate embryopathy is a teratogenic disorder due to acitretin or etretinate exposure during the first trimester of pregnancy, carrying a risk of fetal malformations of approximately 20%, including central nervous system, craniofacial, ear, thymic, cardiac and limb anomalies.
This condition has no sub-types.